GSK closes Bangladesh manufacturing plant, sheds 1,000 workers

By Maggie Lynch contact

- Last updated on GMT


Related tags: Gsk, Manufacturing

GSK is shutting down its Bangladesh manufacturing plant in an effort to streamline its emerging market operations, laying off 1,000 employees in the process.

After reports of this closure spread among workers, protests occurred outside of the plant, according to local paper, DhakaTribune​. The plant’s employee union stated that a vested quarter had been conspiring to close down the plant, and that production had stopped as of July 22. The union sought government intervention according to a local paper.

A GlaxoSmithKline (GSK) spokesperson told us, “Following a business review, GSK Bangladesh Limited is proposing the closure of the commercially unsustainable manufacturing and commercial operations of its pharmaceutical business unit.”

The closure will occur by the end of the year. GSK had previously announced that its emerging markets region will be part of an integrated operation with a different commercial structure.

“Bangladesh has a very vibrant and strong local pharmaceutical industry. All of our medicines are substitutable with generics and therefore, patients should be able to access a range of suitable alternatives,”​ said the GSK spokesperson.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more